Applicability and effectiveness of a brief psychotherapeutic intervention Managing Cancer and Living Meaningfully (CALM) adapted to Dutch cancer care settings

Completed

• Conditions: stage IV malignancy. Cancer that is metastasized to other organs; 10027476

• Registration Number: NL-OMON49301
• Lead Sponsor: Antoni van Leeuwenhoek Ziekenhuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 54

Inclusion Criteria

- >18 years of age
- Fluency in Dutch or English
- No cognitive impairment indicated in the medical record or by the treating
clinician
- Able to provide informed consent
- diagnosis of Stage IV cancer with expected survival of 6-18 months
- OR a diagnosis of stage IV non-small cell lung carcinoma with a response
after 12 weeks of treatment with first line immunotherapy or targeted therapy
with or without chemotherapy OR a stage IV melanoma with a response after 12
weeks of treatment with immunotherapy. Response after 12 weeks is
assessed/determined by the treating physician

Exclusion Criteria

- Patients with a primary psychotic disorder or suicidal intents
- Concurrent psychological or psychiatric treatment elsewhere
- Lack of interest in treatment for their distress
- Major communication difficulties
- Inability to commit to the required 3-6 psychotherapy sessions (e.g., too ill
to participate, lack of transportation, insufficient motivation to participate,
etc.)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>1. Feasibility to implement CALM and acceptability assessed with:<br /><br>a. the percentage of patients that consent to participate<br /><br>b. the percentage of patients that complete at least 3 sessions of CALM<br /><br>therapy after consent and complete study measures<br /><br>c. qualitative interviews<br /><br><br /><br></p><br>